Safety Study of Tecadenoson to Treat Atrial Fibrillation

NCT00713401 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Tecadenoson
DRUG: Esmolol

Sponsor

Gilead Sciences